The findings support an earlier hypothesis by Gabrielli et al. that a stepwise process of SSc development begins with inflammatory (e.g., IFNα signaling) and continues with fibrosis (e.g., PDGF and TGF-β signaling) and ends in atrophy (391). The gene discussed is IFNA1; the disease is systemic sclerosis.